This is a retrospective, prospective, single-centre, non-pharmacological observational study.
The primary objective is to investigate the long-term prognosis of the kidney transplant function of different types of donors.
Age ≥ 18 years.
Kidney transplant recipient from any donor.
Acquisition of Informed Consent to study participation and data processing.
None
The medical records of all patients undergoing kidney transplantation performed at the O.U. Nephrology, Dialysis and Transplantation of IRCCS AOUBO from January 2017 until the start of the study will be retrospectively reviewed. After that, all kidney transplant recipients over the next 9 years, performed c/o the U.O. Nephrology, Dialysis and Transplantation of IRCCS AOUBO, will be prospectively enrolled.
Cohort
Prospective
Not listed
the functionality of kidney transplantation
the functionality of the kidney transplant will be assessed by considering the events of graft failure (return to ESRD, kidney retransplantation), and eGFR change (calculated according to the CKD-EPI formula) at 1 month, 6 months, 1 year, 5 years and 10 years after transplantation. A loss of eGFR of 40% within the first 3 years of follow-up from the baseline visit (at discharge from transplantation) is considered a valid surrogate end-point of ESRD.
Click on the lead sponsor to view all of their trials.
